PUTRAJAYA, Dec 23 (Bernama) — Clinical Research Malaysia (CRM) signed a charter agreement earlier today with Syneos Health, the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success, formalizing the inclusion of CRM-affiliated clinical research sites under the Syneos Health Catalyst Program.
The Syneos Health Catalyst Program brings together clinical research sites and industry partners to deliver consistent quality in clinical trials. Sites under the program have the opportunity to participate in an increased volume of clinical trials as well as harness best practices and insights from other clinical research sites across the globe.